Correlation Between Avadel Pharmaceuticals and II VI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and II VI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and II VI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and II VI Incorporated, you can compare the effects of market volatilities on Avadel Pharmaceuticals and II VI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of II VI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and II VI.

Diversification Opportunities for Avadel Pharmaceuticals and II VI

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Avadel and IIVIP is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and II VI Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on II VI and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with II VI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of II VI has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and II VI go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and II VI

Given the investment horizon of 90 days Avadel Pharmaceuticals is expected to generate 3.43 times less return on investment than II VI. In addition to that, Avadel Pharmaceuticals is 1.72 times more volatile than II VI Incorporated. It trades about 0.04 of its total potential returns per unit of risk. II VI Incorporated is currently generating about 0.26 per unit of volatility. If you would invest  15,205  in II VI Incorporated on September 14, 2024 and sell it today you would earn a total of  3,546  from holding II VI Incorporated or generate 23.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy8.08%
ValuesDaily Returns

Avadel Pharmaceuticals PLC  vs.  II VI Incorporated

 Performance 
       Timeline  
Avadel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
II VI 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days II VI Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, II VI is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Avadel Pharmaceuticals and II VI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avadel Pharmaceuticals and II VI

The main advantage of trading using opposite Avadel Pharmaceuticals and II VI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, II VI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in II VI will offset losses from the drop in II VI's long position.
The idea behind Avadel Pharmaceuticals PLC and II VI Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios